EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms

Ping Zhang iD, Guoyun Wang iD

International Journal of Molecular Sciences · 10.04.2023 · 24 (8) · 6992

DOI: 10.3390/ijms24086992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.04.2023. Verfasst von Ping Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan 250021, China. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Major Program of Shandong Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is an estrogen-dependent disease characterized by the growth of endometrial-like tissue outside the uterus. Progestins are currently the most commonly used treatment for endometriosis because of their excellent therapeutic effects and limited side effects. However, progestins have been unsuccessful in some symptomatic patients. The inability of the endometrium to respond properly to progesterone is known as progesterone resistance. An increasing body of evidence suggests the loss of progesterone signaling and the existence of progesterone resistance in endometriosis. The mechanisms of progesterone resistance have received considerable scholarly attention in recent years. Abnormal PGR signaling, chronic inflammation, aberrant gene expression, epigenetic alterations, and environmental toxins are considered potential molecular causes of progesterone resistance in endometriosis. The general objective of this review was to summarize the evidence and mechanisms of progesterone resistance. A deeper understanding of how these mechanisms contribute to progesterone resistance may help develop a novel therapeutic regimen for women with endometriosis by reversing progesterone resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisProgestinsProgesteroneReceptors, ProgesteroneFemaleHumansEndometriumUterine Diseases

Stichwörter der Autor:innen

endometriosisprogesteroneprogesterone receptorprogesterone resistance

Substanzen

ProgesteroneProgestinsReceptors, Progesterone

Autor:innen und Institutionen

  • Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan 250021, China.
  • Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China.

ORCID-Profile: Ping Zhang, Guoyun Wang

Förderung

  • National Key R&D Program of China
  • Major Program of Shandong Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, P., & Wang, G. (2023). Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms. International Journal of Molecular Sciences, 24(8), 6992. https://doi.org/10.3390/ijms24086992

Vancouver

Zhang P, Wang G. Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms. International Journal of Molecular Sciences. 2023;24(8):6992. doi:10.3390/ijms24086992

BibTeX
@article{Zhang2023,
  author = {Zhang, Ping and Wang, Guoyun},
  title = {Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {8},
  pages = {6992},
  doi = {10.3390/ijms24086992}
}
Kostenlos starten →